Cell Therapy Platforms With Precigen CEO Dr. Helen Sabzevari

We love to hear from our listeners. Send us a message. Learn how Precigen is advancing a deep pipeline of immuno-oncology, infectious disease, and autoimmune disorder candidates through the clinic on the back of its UltraCAR-T platform. CEO Dr. Helen Sabzevari describes the promise of the platform to change the CAR T complexity paradigm with an overnight manufacturing process to affect patients in urgent need of timely therapy. Access this and hundreds of episodes of the Business of B...